Hydrindene derivatives as potential oral hypoglycemic agents: N-alkyl 1,2,3,3a,4,8b-hexahydroindeno(1,2-b)pyrroles.
D000818:Animals; D001786:Blood Glucose; D004837:Epinephrine / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007192:Indenes; D009638:Norepinephrine / Q000378:metabolism; D010625:Phenylethanolamine N-Methyltransferase / Q000037:antagonists & inhibitors; D011758:Pyrroles / Q000138:chemical synthesis / Q000494:pharmacology*; D011817:Rabbits
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007192:Indenes; D011758:Pyrroles; D010625:Phenylethanolamine N-Methyltransferase; D009638:Norepinephrine; D004837:Epinephrine